ONL Therapeutics
Biotechnology Research
524 S Main St
42 employees
- Employees
- 42
- Contacts
- 4
- Emails
- 4
- Phones
- 1
ONL Therapeutics Overview
- Headquarters
- 524 S Main St
- Phone Number
- Available in AeroLeads
- Website
- onltherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 42
- Founded
- 2011
- Funding
- 65.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ONL Therapeutics
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to helping patients see the future. Our mission is to develop innovative therapeutics to protect and improve the vision of patients with a range of retinal disease and conditions. By advancing a breakthrough technology designed to prevent the death of key retinal cells caused by the activation of the natural Fas pathway, ONL is pioneering an entirely new approach to preserve sight. It is the first and only company focused on preventing Fas-mediated death of key retinal cells, which is a root cause of vision loss, a leading cause of blindness and an unaddressed medical need. ONL’s lead therapeutic candidate, ONL1204, is a first-in-class small peptide Fas inhibitor designed to protect retinal cells from both death and inflammatory signaling pathways. ONL1204 Ophthalmic Solution is being developed for the treatment of retinal detachment, an acute condition for which the company has been granted orphan drug designation by the FDA. In addition, the company is currently developing ONL1204 in geographic atrophy associated with age-related macular degeneration, glaucoma, and other acute and chronic indications.
ONL Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 1
- 25.0% coverage
ONL Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nichole R. | Dedicated and Focused Administrator | Ann Arbor, Michigan, United States |
Email
|
| Marian Nakada, Ph.d. | Using Big for Good. Making Strategic | Cambridge, Massachusetts, United States |
Email
|
| Penny Renee Fleck, Mt, Mba | Chief Development Officer at Onl | Weehawken, New Jersey, United States |
Email
|
| Connie Chang | Chief Operating Officer at Onl | Ann Arbor, Michigan, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
13 profiles
Executive
5 profiles
Manager
2 profiles
Intern / trainee
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 3 | 3 | 2 |
| Healthcare | 1 | 1 | 1 |
ONL Therapeutics Tech Stack
Engineering
2 profiles
Compare Similar Companies to ONL Therapeutics
Viridian Therapeutics, Inc.
Biotechnology Research
Bicara Therapeutics
Biotechnology Research
SpectraWAVE, Inc.
Medical Equipment Manufacturing
MBX Biosciences, Inc.
Biotechnology Research
Terns Pharmaceuticals
Biotechnology Research
Oruka Therapeutics
Biotechnology Research
PANTERA
Pharmaceutical Manufacturing
Candid Therapeutics
Biotechnology Research
Superluminal Medicines Inc.
Biotechnology Research
Radiant Biotherapeutics
Biotechnology Research